Search results - 6 results
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
patient-days (pd). Incidence of Central line-associated bloodstream infection (CLABSI) in 2022 was 2.4 episodes per 10,000 pd. Generally, hospital-wide incidences of HABSI show decreasing trends since 2020, ...
Gram-negative central line-associated bloodstream infection incidence peak during the summer: a national seasonality cohort study.
[95% CI 1.11-1.48], p < 0.001). Subgroup analysis replicated this trend for CLABSI diagnosed in the intensive care unit. Only gram-negative CLABSI rates were associated with increased temperature (IRR ...
Healthcare-associated infections and antimicrobial use in Belgian nursing homes: results of three point prevalence surveys between 2010 and 2016
1.4-2.7%) in HALT-1 to 3.2% (95% CI: 2.2-4.2%) in HALT-2 and 2.7% (95% CI: 2.1-3.4%) in HALT-3. Our post-hoc analysis on the cohort (n = 25 NH s) found similar trends. In all three surveys, respiratory tract ...
Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.
on a national level are scarce although of high interest to compare trends and the associated epidemiology in other countries and to assess the need for antifungal stewardship programmes. OBJECTIVES: ...
Care Infections & Antibiotic Resistance in Belgium
antimicrobial resistance in Belgium. The positive downward trend we have been observing for many years in the incidence of Methicillin Resistant Staphylococcus aureus (MRSA) in acute care hospitals appears to be ...
How to report central line-associated bloodstream infections in surveillance? A comparison of three classifications in Belgium.
CLABSI incidence and trends. Materials/methods: To be considered as CLABSI in the Belgian bloodstream infection surveillance, a CLABSI must first meet the surveillance definition for hospital-associated ...